Molecule AG
Tyler Golato is the Co-Founder and Chief Executive Officer of Molecule GmbH. Tyler is also the Co-Initiator of VitaDAO, a decentralized collective funding early stage longevity research. In addition, Tyler serves as a Founding Fellow/Longevity Biotech at On Deck. With a background in research and clinical observation at organizations such as the National Institutes of Health and Johns Hopkins Bayview Medical Center, Tyler brings a wealth of experience in the field of oncology and molecular gerontology. Tyler has a Bachelor of Science in Biochemistry and Molecular Biology from Stockton University.
Molecule AG
Molecule is a software platform used to accelerate innovation in the pharmaceutical industry. The company was founded in 2019 by Paul Kohlhaas and is headquartered in Berlin, Germany.